The neighbourhood pharmacy chain is now operating in Noida, Badarpur, Faridabad, Shahdara and Dwarka, offering 100% genuine medicines, personal care and daily essentials with fast, reliable service.
QuickLife Pharmacy has opened at select locations in Delhi NCR as a neighbourhood destination for genuine medicines, personal care and wellness essentials. The chain is now operating in Noida, Badarpur, Faridabad, Shahdara and Dwarka, built on a simple idea: when it comes to your health, there is no room for compromise.
The launch enters one of the world’s fastest-growing pharmacy markets. India’s pharmaceutical market was valued at USD 68.38 billion in 2025 and is projected to reach USD 174.67 billion by 2034, with a compound annual growth rate of nearly 11%, according to industry research. North India, led by Delhi NCR, accounts for roughly 30% of the national market, making the region one of the most significant in the country for medicine access.
Online pharmacy is the fastest-growing part of that market, valued at USD 3.71 billion in 2025 and projected to reach USD 14.08 billion by 2034 with a compound annual growth rate of about 16%. Even so, physical pharmacies remain the backbone of everyday healthcare, valued for immediate dispensing and face-to-face guidance. QuickLife is built for both, pairing neighbourhood stores with fast home delivery so that customers get convenience without giving up the reassurance of a physical pharmacy.
At the heart of QuickLife’s promise is authenticity. Counterfeit and substandard medicines remain a stubborn concern in India: studies cited by the US Trade Representative have suggested that up to 20% of drugs sold in the country could be counterfeit, though official government estimates place the share considerably lower. QuickLife stocks only genuine medicines and healthcare products sourced through licensed channels, so people never have to second-guess what they are buying.
Demand for dependable pharmacy access is also structurally recurring. India is home to an estimated 77 million adults living with type 2 diabetes and around 25 million more who are prediabetic, and when hypertension and cardiac conditions are Considered, well over 100 million people rely on ongoing prescription refills. For NCR’s ageing, high-chronic-load households, having a trusted pharmacy on the doorstep matters month after month, not only in a one-off emergency.
QuickLife also reaches beyond the prescription counter. Alongside medicines, every store carries personal care and daily wellness essentials, a category on a steep growth curve, with India’s beauty and personal care market alone worth about USD 31 billion in 2025. The result is one trusted place where a family can collect a prescription, restock everyday health and hygiene products and pick up wellness items in a single visit.
At every QuickLife store, customers will find:
Genuine medicines & healthcare products: 100% authentic products sourced through licensed channels, so families can buy with confidence.
Personal care & daily essentials: everyday health, hygiene and wellness products under one roof.
Fast & reliable service: quick, dependable fulfilment whether customers walk in or place an order for delivery.
“We wanted QuickLife to be the pharmacy people can rely on right in their own neighbourhood,” said a spokesperson from the QuickLife team. “Genuine products, helpful service and quick access: that is what good health deserves. It is not something any family should have to compromise on, and that belief runs through everything we stock and every order we deliver.”
ABOUT QUICKLIFE
QuickLife Pharmacy is a Delhi NCR-based neighbourhood pharmacy chain offering genuine medicines, personal care and wellness essentials with fast, reliable service. Founded in 2025, QuickLife operates a growing network of stores across select NCR locations, including Noida, Badarpur, Faridabad, Shahdara and Dwarka. For more information, our website is launching soon at quicklifenow.com.
For media inquiries:
- Spokesperson: Mr. Vipul Vaibhav
- Email Address: care@quicklifenow.com
- Contact No.: +91 60065 00300
Market figures are drawn from publicly available industry research (IMARC Group, Ken Research and Nexdigm) and from counterfeit-medicine estimates cited by the Office of the US Trade Representative. Figures reflect the latest available data as of 2026.
This Press Release has not been vetted by The Eastern Herald and is sourced by VMPL
